Literature DB >> 3038865

Nonselective inhibition of neutrophil functions by sphinganine.

D Pittet, K H Krause, C B Wollheim, R Bruzzone, D P Lew.   

Abstract

Sphinganine has been proposed to be a specific inhibitor of protein kinase C. In the present study we have evaluated whether sphinganine is a convenient tool to probe for the role of protein kinase C in neutrophil function. Human neutrophils were loaded with the fluorescent probe quin2 and then tested in parallel for cytosolic free Ca2+, [Ca2+]i, membrane potential changes, O2- production, and exocytosis of primary granules (containing beta-glucuronidase) in response to various stimuli. In addition to inhibiting O2- production and exocytosis in a dose-dependent manner, sphinganine also blocked formyl-methionyl-leucyl-phenylalanine-induced [Ca2+]i, transients. Furthermore, sphinganine inhibited exocytosis elicited by the calcium ionophore ionomycin. Although sphinganine blocked O2- production due to phorbol 12-myristate 13-acetate, the most striking finding was that the drug rendered the cells leaky. Thus, at similar concentrations as those inhibiting cellular functions, sphinganine was shown to lead to cell permeabilization, as assessed by release of quin2 and cytoplasmic markers into the extracellular medium, and changes in plasma membrane potential. We conclude, therefore, that sphinganine does not appear to be a suitable compound for the evaluation of the involvement of protein kinase C in neutrophil activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038865

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Protein kinase C does not regulate diacylglycerol metabolism in aortic smooth muscle cells.

Authors:  M Chuang; K R Dell; D L Severson
Journal:  Mol Cell Biochem       Date:  1990-07-17       Impact factor: 3.396

Review 2.  Activation and regulation of protein kinase C enzymes.

Authors:  G L Nelsestuen; M D Bazzi
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

3.  Neutrophil bactericidal activity against Staphylococcus aureus adherent on biological surfaces. Surface-bound extracellular matrix proteins activate intracellular killing by oxygen-dependent and -independent mechanisms.

Authors:  M Hermann; M E Jaconi; C Dahlgren; F A Waldvogel; O Stendahl; D P Lew
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

4.  A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.

Authors:  Carolyn D Britten; Elizabeth Garrett-Mayer; Steven H Chin; Keisuke Shirai; Besim Ogretmen; Tricia A Bentz; Alan Brisendine; Kate Anderton; Susan L Cusack; Lynn W Maines; Yan Zhuang; Charles D Smith; Melanie B Thomas
Journal:  Clin Cancer Res       Date:  2017-04-18       Impact factor: 12.531

5.  Inhibitors of protein kinase C prolong the falling phase of each free-calcium transient in a hormone-stimulated hepatocyte.

Authors:  A Sanchez-Bueno; C J Dixon; N M Woods; K S Cuthbertson; P H Cobbold
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

Review 6.  The role of neutrophils in vascular injury: a summary of signal transduction mechanisms in cell/cell interactions.

Authors:  G Weissmann
Journal:  Springer Semin Immunopathol       Date:  1989

7.  Regulation of sn-1,2-diacylglycerol second-messenger formation in thrombin-stimulated human platelets. Potentiation by protein kinase C inhibitors.

Authors:  W R Bishop; J August; J M Petrin; J K Pai
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

8.  Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism.

Authors:  T Hashizume; T Sato; T Fujii
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

9.  Zymosan-triggered tyrosine phosphorylation in mouse bone-marrow-derived macrophages is enhanced by respiratory-burst priming agents.

Authors:  S P Green; J A Hamilton; W A Phillips
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

10.  Use of D-erythro-sphingosine as a pharmacological inhibitor of protein kinase C in human platelets.

Authors:  W A Khan; S W Mascarella; A H Lewin; C D Wyrick; F I Carroll; Y A Hannun
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.